Harmony Biosciences Holdings, Inc. - Common Stock, $0.00001 par value per share (HRMY)

Historical Holders from Q3 2020 to Q3 2025

Symbol
HRMY on Nasdaq
CUSIP
413197104
Type / Class
Equity / Common Stock, $0.00001 par value per share
Shares outstanding
57.4M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
47.3M
Holdings value
$1.3B
% of all portfolios
0.009%
Grand Portfolio weight change
0%
Number of holders
290
Number of buys
155
Number of sells
-113
Average Value change %
-0.03%
Average buys %
+0.001%
Average sells %
-0.03%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Harmony Biosciences Holdings, Inc. - Common Stock, $0.00001 par value per share (HRMY)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Marshman Fund Trust II 10.6% $170M 6.05M Marshman Fund Trust II Dec 31, 2024
BlackRock, Inc. 10.1% -17.5% $162M -$33.7M 5.77M -17.2% BlackRock, Inc. Mar 31, 2025
VANGUARD GROUP INC 8.3% $133M 4.73M The Vanguard Group Dec 31, 2024
FMR LLC 6.7% $106M 3.85M FMR LLC Sep 30, 2025

Institutional Holders of Harmony Biosciences Holdings, Inc. - Common Stock, $0.00001 par value per share (HRMY)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 47.3M $1.3B -$115M $27.56 290
2025 Q2 51.2M $1.62B +$22.9M $31.60 275
2025 Q1 50.1M $1.66B -$101M $33.19 266
2024 Q4 52.7M $1.81B +$76.2M $34.41 244
2024 Q3 49.7M $1.99B -$3.86M $40.00 231
2024 Q2 50.2M $1.51B +$39.7M $30.17 218
2024 Q1 48.8M $1.64B +$42.7M $33.58 207
2023 Q4 38.2K $1.25M +$137K $32.82 2
2023 Q3 49.3M $1.62B -$87.1M $32.77 200
2023 Q2 51.7M $1.82B +$16.4M $35.19 204
2023 Q1 51.2M $1.67B -$29.5M $32.65 211
2022 Q4 51M $2.81B +$33.8M $55.10 235
2022 Q3 50.4M $2.24B +$101M $44.29 190
2022 Q2 47.8M $2.32B +$88.9M $48.77 170
2022 Q1 45.8M $2.23B +$78.3M $48.65 165
2021 Q4 44.3M $1.89B +$101M $42.64 136
2021 Q3 30.9M $1.18B +$115M $38.33 96
2021 Q2 27.9M $786M -$9.32M $28.23 78
2021 Q1 27.5M $908M -$18.5M $33.04 56
2020 Q4 28M $998M -$18.7M $36.15 59
2020 Q3 28.5M $941M +$941M $33.90 44